title: Comparative assessment of the ligand and metal ion binding properties of integrins alpha9beta1 and alpha4beta1.
abstract: Integrins alpha9beta1 and alpha4beta1 form a distinct structural class, but while alpha4beta1 has been subjected to extensive study, alpha9beta1 remains poorly characterized. We have used the small molecule N-(benzenesulfonyl)-(L)-prolyl-(L)-O-(1-pyrrolidinylcarbonyl)tyrosine (3) to investigate the biochemical properties of alpha9beta1 and directly compare these properties with those of alpha4beta1. Compound 3 has a high affinity for both integrins with K(D) values of < or =3 and 180 pM for alpha9beta1 in 1 mM Mn2+ (activating) and 1 mM Ca2+ and 1 mM Mg2+ (nonactivating) conditions and < or =5 and 730 pM for alpha4beta1 under the corresponding conditions. Ca2+ treatment promoted the binding of 3 to both integrins (EC50 = 30 microM Ca2+ in both cases). Compound 3 binding to both integrins was also stimulated by the addition of the activating monoclonal antibody TS2/16. These findings indicate that the mechanisms by which metal ions and TS2/16 regulate ligand binding to alpha9beta1 and alpha4beta1 are similar. The binding of 3 to both integrins induced the mAb 9EG7 LIBS epitope, a property consistent with occupancy of the receptor's ligand binding site by 3. But whereas EGTA treatment inhibited the binding of 9EG7 to alpha4beta1, it stimulated the binding of 9EG7 to alpha9beta1. The 9EG7 and TS2/16 effects point to contributions of the beta1-chains on binding. Cross-linking data revealed that the integrin alpha-chains are also involved in binding the small molecule, as stable linkages were observed on both the alpha9 chain of alpha9beta1 and the alpha4 chain of alpha4beta1. Extensive structure-activity analyses with natural and synthetic ligands indicate distinct features of the ligand binding pockets. Most notable was the estimated >1000-fold difference in the affinity of the integrins for VCAM-1, which binds alpha4beta1with an apparent K(D) of 10 nM and alpha9beta1 with an apparent K(D) of >10 microM. Differences were also seen in the binding of alpha9beta1 and alpha4beta1 to osteopontin. Compound 3 competed effectively for the binding of VCAM-1 and osteopontin to both integrins. While these studies show many similarities in the biochemical properties of alpha9beta1 and alpha4beta1, they identify important differences in their structure and function that can be exploited in the design of selective alpha9beta1 and alpha4beta1 inhibitors.
authors.affiliation: Biogen, Inc., 14 Cambridge Center, Cambridge, Massachusetts 02142, USA. blake_pepinsky@biogen.com
authors.forename: R Blake
authors.initials: RB
authors.lastname: Pepinsky
authors.forename: Richard A
authors.initials: RA
authors.lastname: Mumford
authors.forename: Ling Ling
authors.initials: LL
authors.lastname: Chen
authors.forename: Diane
authors.initials: D
authors.lastname: Leone
authors.forename: Suzanne E
authors.initials: SE
authors.lastname: Amo
authors.forename: Gail Van
authors.initials: GV
authors.lastname: Riper
authors.forename: Adrian
authors.initials: A
authors.lastname: Whitty
authors.forename: Brian
authors.initials: B
authors.lastname: Dolinski
authors.forename: Roy R
authors.initials: RR
authors.lastname: Lobb
authors.forename: Dennis C
authors.initials: DC
authors.lastname: Dean
authors.forename: Linda L
authors.initials: LL
authors.lastname: Chang
authors.forename: Conrad E
authors.initials: CE
authors.lastname: Raab
authors.forename: Qian
authors.initials: Q
authors.lastname: Si
authors.forename: William K
authors.initials: WK
authors.lastname: Hagmann
authors.forename: Russell B
authors.initials: RB
authors.lastname: Lingham
mesh_terms: D001667:Binding, Competitive / Q000502:physiology; D002118:Calcium / Q000378:metabolism; D004151:Dipeptides / Q000138:chemical synthesis / Q000378:metabolism*; D006801:Humans; D039041:Integrin alpha4beta1; D016023:Integrins / Q000037:antagonists & inhibitors / Q000378:metabolism*; D019169:Jurkat Cells; D020014:K562 Cells; D008024:Ligands; D008274:Magnesium / Q000378:metabolism; D008345:Manganese / Q000378:metabolism; D008670:Metals / Q000378:metabolism*; D009842:Oligopeptides / Q000378:metabolism; D053495:Osteopontin; D011485:Protein Binding / Q000502:physiology; D016201:Receptors, Lymphocyte Homing / Q000037:antagonists & inhibitors / Q000378:metabolism*; D012795:Sialoglycoproteins / Q000378:metabolism* / Q000494:pharmacology; D013450:Sulfones / Q000138:chemical synthesis / Q000378:metabolism*; D019010:Vascular Cell Adhesion Molecule-1 / Q000378:metabolism* / Q000494:pharmacology
chemical_list: D004151:Dipeptides; D039041:Integrin alpha4beta1; D016023:Integrins; D008024:Ligands; D008670:Metals; C459088:N-(benzenesulfonyl)-prolyl-O-(1-pyrrolidinylcarbonyl)tyrosine; D009842:Oligopeptides; D016201:Receptors, Lymphocyte Homing; C506895:SPP1 protein, human; D012795:Sialoglycoproteins; D013450:Sulfones; D019010:Vascular Cell Adhesion Molecule-1; C113256:integrin alpha 9 beta 1; D053495:Osteopontin; D008345:Manganese; D008274:Magnesium; D002118:Calcium